Angola vs Somalia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Somalia
4.0%
in 2024
Angola rank
5th
Somalia rank
2nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Somalia
How they compare
Somalia currently reports 4.0% against 3.1% in Angola, a difference of 0.9%.
That makes Somalia's figure about 1.3 times Angola's.
Across all 10 years both countries report, Somalia has been ahead every year.
Angola ranks 5th and Somalia ranks 2nd of 215 countries.
Somalia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 6.4% | 3.8% | Somalia |
| 2020s | 3.0% | 4.4% | 1.4% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Somalia?
- Somalia, at 4.0% against 3.1% in Angola as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Somalia?
- 0.9%, with Somalia ahead.
- How many years of comparable data are there for Angola and Somalia?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Somalia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Somalia ranks 2nd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.